"Huntingtin Holiday": Progress toward an Antisense Therapy for Huntington's Disease

被引:41
作者
Lu, Xiao-Hong [1 ,2 ,3 ]
Yang, X. William [1 ,2 ,3 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Inst Brain Res, Los Angeles, CA 90095 USA
关键词
MUTANT HUNTINGTIN; MOUSE MODEL; MICE; OLIGONUCLEOTIDES; NEUROPATHOLOGY; PATHOGENESIS; BRAIN; MOTOR;
D O I
10.1016/j.neuron.2012.06.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Lowering mutant Huntingtin is a consensus therapeutic strategy for Huntington's disease. In this issue of Neuron, Kordasiewicz et al. (2012) show the benefit of transient antisense oligonucleotide (ASO) therapy to degrade Huntingtin mRNA and elicit sustained therapeutic benefit in HD mice.
引用
收藏
页码:964 / 966
页数:3
相关论文
共 50 条
  • [1] Huntingtin-Lowering Strategies in Huntington's Disease: Antisense Oligonucleotides, Small RNAs, and Gene Editing
    Aronin, Neil
    DiFiglia, Marian
    MOVEMENT DISORDERS, 2014, 29 (11) : 1455 - 1461
  • [2] Huntington's disease: progress toward effective disease-modifying treatments and a cure
    Johnson, Carl D.
    Davidson, Beverly L.
    HUMAN MOLECULAR GENETICS, 2010, 19 : R98 - R102
  • [3] Huntington's Disease: Function and Dysfunction of Huntingtin in Axonal Transport
    Saudou, Frederic
    Humbert, Sandrine
    INTRACELLULAR TRAFFIC AND NEURODEGENERATIVE DISORDERS, 2009, : 115 - +
  • [4] Moving toward a gene therapy for Huntington's disease
    Glorioso, J. C.
    Cohen, J. B.
    Carlisle, D. L.
    Munoz-Sanjuan, I.
    Friedlander, R. M.
    GENE THERAPY, 2015, 22 (12) : 931 - 933
  • [5] Progress and Challenges in RNA Interference Therapy for Huntington Disease
    Harper, Scott Q.
    ARCHIVES OF NEUROLOGY, 2009, 66 (08) : 933 - 938
  • [6] Huntingtin suppression restores cognitive function in a mouse model of Huntington's disease
    Southwell, Amber L.
    Kordasiewicz, Holly B.
    Langbehn, Douglas
    Skotte, Niels H.
    Parsons, Matthew P.
    Villanueva, Erika B.
    Caron, Nicholas S.
    Ostergaard, Michael E.
    Anderson, Lisa M.
    Xie, Yuanyun
    Dal Cengio, Louisa
    Findlay-Black, Hailey
    Doty, Crystal N.
    Fitsimmons, Bethany
    Swayze, Eric E.
    Seth, Punit P.
    Raymond, Lynn A.
    Bennett, C. Frank
    Hayden, Michael R.
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (461)
  • [7] HUNTINGTON'S DISEASE Flipping a switch on huntingtin
    Greiner, Erin R.
    Yang, X. William
    NATURE CHEMICAL BIOLOGY, 2011, 7 (07) : 412 - 415
  • [8] Methylene Blue Modulates Huntingtin Aggregation Intermediates and Is Protective in Huntington's Disease Models
    Sontag, Emily Mitchell
    Lotz, Gregor P.
    Agrawal, Namita
    Tran, Andrew
    Aron, Rebecca
    Yang, Guocheng
    Necula, Mihaela
    Lau, Alice
    Finkbeiner, Steven
    Glabe, Charles
    Marsh, J. Lawrence
    Muchowski, Paul J.
    Thompson, Leslie M.
    JOURNAL OF NEUROSCIENCE, 2012, 32 (32) : 11109 - 11119
  • [9] A Huntingtin Knockin Pig Model Recapitulates Features of Selective Neurodegeneration in Huntington's Disease
    Sen Yan
    Tu, Zhuchi
    Liu, Zhaoming
    Fan, Nana
    Yang, Huiming
    Yang, Su
    Yang, Weili
    Zhao, Yu
    Ouyang, Zhen
    Lai, Chengdan
    Yang, Huaqiang
    Li, Li
    Liu, Qishuai
    Shi, Hui
    Xu, Guangqing
    Zhao, Heng
    Wei, Hongjiang
    Pei, Zhong
    Li, Shihua
    Lai, Liangxue
    Li, Xiao-Jiang
    CELL, 2018, 173 (04) : 989 - +
  • [10] Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease
    Wang, Nan
    Gray, Michelle
    Lu, Xiao-Hong
    Cantle, Jeffrey P.
    Holley, Sandra M.
    Greiner, Erin
    Gu, Xiaofeng
    Shirasaki, Dyna
    Cepeda, Carlos
    Li, Yuqing
    Dong, Hongwei
    Levine, Michael S.
    Yang, X. William
    NATURE MEDICINE, 2014, 20 (05) : 540 - 545